Renal amyloidosis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence/Prevalence=== | ===Incidence/Prevalence=== | ||
*Epidemiological information is limited on amyloidosis suggesting differences between population based and case series data with respect to | *Epidemiological information is limited on amyloidosis suggesting differences between population based and case series data with respect to age and race.<ref name="pmid7954866">{{cite journal |vauthors=Simms RW, Prout MN, Cohen AS |title=The epidemiology of AL and AA amyloidosis |journal=Baillieres Clin Rheumatol |volume=8 |issue=3 |pages=627–34 |date=August 1994 |pmid=7954866 |doi= |url=}}</ref> | ||
===Mortality rate=== | ===Mortality rate=== | ||
Revision as of 17:47, 25 July 2018
|
Renal amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Template:Renal amyloidosis On the Web |
|
American Roentgen Ray Society Images of Renal amyloidosis epidemiology and demographics |
|
Risk calculators and risk factors for Renal amyloidosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Epidemiology and Demographics
Incidence/Prevalence
- Epidemiological information is limited on amyloidosis suggesting differences between population based and case series data with respect to age and race.[1]
Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- In renal amyloidosis, is usually first diagnosed in average age of 65 years and it is uncommon before age of 40.[2][3]
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- In renal amyloidosis, the male to female ratio is approximately 2 to 1.[2]
Region
- ALECT2 is more frequent in the United States area.[4]
- AFib cases are most reported in Europe countries.
References
- ↑ Simms RW, Prout MN, Cohen AS (August 1994). "The epidemiology of AL and AA amyloidosis". Baillieres Clin Rheumatol. 8 (3): 627–34. PMID 7954866.
- ↑ 2.0 2.1 Khalighi MA, Dean Wallace W, Palma-Diaz MF (April 2014). "Amyloid nephropathy". Clin Kidney J. 7 (2): 97–106. doi:10.1093/ckj/sfu021. PMC 4377792. PMID 25852856.
- ↑ Hajra A, Bandyopadhyay D (2016). "An interesting case of renal amyloidosis". Indian J Nephrol. 26 (6): 467–469. doi:10.4103/0971-4065.177143. PMC 5131391. PMID 27942184.
- ↑ Said SM, Sethi S, Valeri AM, Leung N, Cornell LD, Fidler ME, Herrera Hernandez L, Vrana JA, Theis JD, Quint PS, Dogan A, Nasr SH (September 2013). "Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases". Clin J Am Soc Nephrol. 8 (9): 1515–23. doi:10.2215/CJN.10491012. PMC 3805078. PMID 23704299.